This is a StreetInsider.com Premium Only Page

Immunogen (IMGN) – PRNewswire

Feb 12, 2024 07:37 AM AbbVie Completes Acquisition of ImmunoGen

Nov 30, 2023 07:30 AM AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio

Oct 23, 2023 08:30 AM Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board

Jul 24, 2023 06:30 AM ImmunoBiochem Announces Multi-Target License and Option Agreement with ImmunoGen to Develop Next-Generation Antibody-Drug Conjugates

Dec 13, 2022 05:00 AM Biosion Announces Research Collaboration with ImmunoGen to Create Novel Antibody-Drug Conjugates